Status:
COMPLETED
Validity and Reliability of the Turkish Version of Atrial Fibrillation Impact Questionnaire (AFImpact)
Lead Sponsor:
Bezmialem Vakif University
Collaborating Sponsors:
Istanbul University - Cerrahpasa
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-99 years
Brief Summary
Validity and reliability of the Turkish version of 'Atrial Fibrillation Impact Questionnaire (AFImpact)' will be evaluated in the study.
Detailed Description
Atrial fibrillation (AF) is the most common sustained arrhythmia with a reported incidence of 2.1% in Turkish population aged 60 and above. Although a minority of patients have minimal or no symptoms,...
Eligibility Criteria
Inclusion
- Diagnosis of paroxysmal, persistant or permanent atrial fibrillation
- To be able to read and understand Turkish
Exclusion
- Diagnosis of heart failure or any chronic lung diseases
- Recent coronary bypass surgery
- Previous heart valve surgery
- Rheumatic valvular heart disease
- Recent acute myocardial infarction
- Having a pacemaker
Key Trial Info
Start Date :
August 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 21 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04047381
Start Date
August 8 2019
End Date
October 21 2019
Last Update
October 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University- Cerrahpasa, Institute of Cardiology
Istanbul, Turkey (Türkiye)